60 search results for: patient burden

The <b>Patient</b> <b>Burden</b> of Chronic Pruritus of Unknown Origin (CPUO)
Dermatology
The Patient Burden of Chronic Pruritus of Unknown Origin (CPUO)
Infographic

An infographic describing the etiology, epidemiology, challenges in diagnosis and patient burden of CPUO.

View more
<b>Patient</b> <b>Burden</b> in Eosinophilic Esophagitis
Gastroenterology
Patient Burden in Eosinophilic Esophagitis
expert video

Drs. Kathryn Peterson and Ikuo Hirano and Profs. Ingrid Terreehorst and Arjan Bredenoord highlight the impact and burden of EoE on the quality of life of patients.

View more
Cracking the Code: Diagnosing and Managing Skin Diseases With Type 2 Inflammation
Dermatology
Cracking the Code: Diagnosing and Managing Skin Diseases With Type 2 Inflammation
expert video

This symposium delves into the pivotal role of type 2 inflammation in diverse skin conditions, including atopic dermatitis, prurigo nodularis, chronic spontaneous urticaria, and bullous pemphigoid. It highlights both shared and distinct disease mechanisms and patient burdens, providing crucial insights for optimizing clinical management strategies through a series of engaging panel discussions with Drs Eichenfield, Elmariah, Culton, and Hawkes.

View more
Coexisting Type 2 Inflammatory Diseases Can Add to the <b>Patient</b> Overall Disease <b>Burden</b>
Type 2 Inflammation
Coexisting Type 2 Inflammatory Diseases Can Add to the Patient Overall Disease Burden
expert video

In this soundbite video from the April 2025 ADVENT Forum in Lisbon, Portugal, Prof. Oscar Palomares highlights how patients with type 2 inflammatory diseases often experience multimorbidities, with overlapping symptoms that amplify their overall disease burden and impact quality of life.

View more
Time to Act: Reducing the Impact of Uncontrolled Disease Through Early Intervention
Dermatology
Time to Act: Reducing the Impact of Uncontrolled Disease Through Early Intervention
expert video

Dr Jason Hawkes describes the importance of early intervention for patients with uncontrolled skin diseases and the effectiveness of evidence-based management strategies, sharing a patient case and his clinical insights with chronic spontaneous urticaria. Drs Eichenfield, Elmariah, and Culton join to review the burdens faced by patients with atopic dermatitis, prurigo nodularis, and bullous pemphigoid, respectively. 

View more
Explore the Global <b>Burden</b> of Pediatric AD (PEDISTAD)
Dermatology
Explore the Global Burden of Pediatric AD (PEDISTAD)
interactivity

This interactive tool allows you to explore the global burden of AD in pediatric patients <12 years from the PEDISTAD Study.

View more
ADVENT at NAPNAP 2025
Congress
12
March
2025
Congress
ADVENT at NAPNAP 2025

Join experts Jonathan Spergel, MD, PhD, Wanda Phipatanakul, MD, MS, and Jerry Ellen Schonfeld, CPNP, at an educational symposium as they investigate the role of type 2 inflammation in pediatric diseases. The speakers will also discuss the difficulties in diagnosis and burdens patients and their families face.

ERS-ISIAN 2023 | From Endotype to Phenotype: Linking Pathophysiology to <b>Burden</b> and Clinical Management for <b>Patient</b>s with Uncontrolled and/or Severe CRSwNP
Rhinology
ERS-ISIAN 2023 | From Endotype to Phenotype: Linking Pathophysiology to Burden and Clinical Management for Patients with Uncontrolled and/or Severe CRSwNP
expert video

Prof. Peter Hellings discusses the interconnection between the pathophysiology, burden and clinical management of uncontrolled and/or severe CRSwNP

View more
The Weight of Breath: The Impact of Pediatric Asthma on <b>Patient</b>s and Caregivers
Pulmonology
The Weight of Breath: The Impact of Pediatric Asthma on Patients and Caregivers
videoanimation

Learn about the multifaceted burden of uncontrolled pediatric asthma on patients and their caregivers.

View more
.
Congress
9
March
2024
Congress
The Benefits of Early Intervention in AD: More Than Skin Deep

Many AD treatment goals focus on clinical manifestations, so that if a patient is free of lesions, their disease is considered well controlled. However, the inflammatory process underlying AD reaches far beyond the skin, affecting patients in unique ways at different stages of their lives. Education on the importance of treating AD beyond the skin and altering the treatment approach to fit the individual patient will help improve clinical management and reduce long-term patient burden.

ADVENT at ESPGHAN | Shedding Light on Pediatric Eosinophilic Esophagitis: Timely Identification and Management
Congress
17
May
2024
Congress
ADVENT at ESPGHAN | Shedding Light on Pediatric Eosinophilic Esophagitis: Timely Identification and Management

Join global experts Prof. Salvatore Oliva and Dr. Dhandapani Ashok for an educational symposium at ESPGHAN, as they discuss the burden and impact of underlying type 2 inflammation in eosinophilic esophagitis (EoE), and the importance of early diagnosis and management in pediatric patients.

ADVENT at IRS-ISIAN | The Importance of Understanding Smell Loss and Congestion in CRSwNP
Congress
5
April
2024
Congress
ADVENT at IRS-ISIAN | The Importance of Understanding Smell Loss and Congestion in CRSwNP

Join Profs. Sachio Takeno and Joaquim Mullol for an educational symposium highlighting the multifaceted burden associated with loss of smell and congestion in patients with uncontrolled CRSwNP.